Martine Kruijtbosch

112 Chap t e r 3. 2 REFERENCES 1. Pauwels K, Huys I, Casteels M, Simoens S. Drug shortages in European countries: A trade-off between market attractiveness and cost containment? BMC Health Serv Res 2014;14:438-447. 2. Lipworth W, Kerridge I. Why drug shortages are an ethical issue. Australas Med J 2013;6:556-559. 3. Fox ER, Sweet BV, Jensen V. Drug shortages: A complex health care crisis. Mayo Clin Proc 2014;89:361-373. 4. Dill S, Ahn J. Drug shortages in developed countries--reasons, therapeutic consequences, and handling. Eur J Clin Pharmacol 2014;70:1405-1412. 5. De Weerdt E, Simoens S, Casteels M, Huys I. Clinical, economic and policy implications of drug shortages in the European Union. Appl Health Econ Health Policy 2017;15:441-445. 6. Bochenek T, Abilova V, Alkan A, Asanin B, de Miguel Beriain I, Besovic Z, et al. Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian countries. Front Pharmacol 2018;8:942. 7. Postma DJ, De Smet, P A G M, Gispen-de Wied CC, Leufkens HGM, Mantel-Teeuwisse AK. Drug shortages from the perspectives of authorities and pharmacy practice in the Netherlands: An observational study. Front Pharmacol 2018;9:1243. 8. Bogaert P, Bochenek T, Prokop A, Pilc A. A qualitative approach to a better understanding of the problems underlying drug shortages, as viewed from Belgian, French and the European Union’s perspectives. PLoS One 2015;10:0125691. 9. Tan YX, Moles RJ, Chaar BB. Medicine shortages in Australia: Causes, impact and management strategies in the community setting. Int J Clin Phar 2016;38:1133-1141. 10. McLaughlin M, Kotis D, Thomson K, Harrison M, Fennessy G, Postelnick M, et al. Effects on patient care caused by drug shortages: A survey. J Manag Care Pharm 2013;19:783-788. 11. Said A, Goebel R, Ganso M, Zagermann-Muncke P, Schulz M. Drug shortages may compromise patient safety: Results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists. Health Policy 2018;122:1302-1309. 12. Rider AE, Templet DJ, Daley MJ, Shuman C, Smith LV. Clinical dilemmas and a review of strategies to manage drug shortages. J Pharm Pract 2013;26:183-191. 13. Walker J, Chaar BB, Vera N, Alvish S. Pillai AS, Lim JS, et al. Medicine shortages in Fiji: A qualitative exploration of stakeholders’ views. PLoS One 2017;12:1-16. 14. Javadi M, Ashrafi N, Salari P. Assessment of pharmacists experiences and attitudes toward professionalism and its challenges in pharmacy practice. Iran J Pharm Res 2018;17:168-177. 15. Kälvemark S, Höglund AT, Hansson MG, Westerholm P, Arnetz B. Living with conflicts-ethical dilemmas and moral distress in the health care system. Soc Sci Med 2004;58:1075-1084. 16. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-543. 17. Gulbis BE, Ruiz MC, Denktas AE. The impact of drug shortages on the pharmacy, nursing, and medical staff's ability to effectively care for critically ill patients. Crit Care Nurs Q 2013;36:400-406.